Keyword: American Association for Cancer Research
The week’s biotech discoveries included an I-O triple therapy against ovarian cancer and a single protein target for three diseases.
A CD40-activating antibody combined with BMS's Opdivo and chemo shrunk tumors in 20 out of 24 patients with pancreatic cancer.
Phase 2b data showed TG Therapeutics’ umbralisib partially shrank tumors in 33% and eradicated them in 19% of marginal zone lymphoma patients.
Positive data from a mouse trial of a cancer-preventing vaccine has Weill Cornell researchers planning a trial in people with a genetic predisposition.
CAR-T has seen a host of successes in blood cancers, but translating that into solid tumors has proven much more difficult.
An NCI team is reporting promising results from a small trial of a dendritic-cell vaccine in patients whose tumors overexpress HER2.
A compound that transforms into an antifungal drug as the body metabolizes it inhibits the progression of bladder cancer in mouse models.